GEHC

GE HealthCare Technologies Inc.

HealthcareMedical DevicesNASDAQ

$72.69

+$2.52 (3.47%)today

Conviction

0/ 10

Fair Value$93.47

Upside+28.59%

Signal0

Market Cap$31.4B

52W Range$57.65–$89.77

Next EarningsApr 29

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$76.28

Current Price$69.23

Upside / Down+10.2%

P(Undervalued)64.4%

P(20%+ Up)36.0%

P(15%+ Down)17.5%

Fair Value Distribution — percentile bands

64.4% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

1.9%/yr

±5.3% · revenue growth to justify current price

FCF-Based Reverse DCF

17.7%/yr

±3.0% · FCF growth to justify current price

THE GAP

Market pricing margin compression or rising capex

KEY VALUE DRIVERS

Spearman correlation — what moves this valuation most

Quick Take

GE HealthCare Technologies Inc.

Trailing P/E15.1x

Forward P/E12.4x

P/S1.5x

EPS (TTM)$4.55

Analyst Target$93.47

Analyst Upside28.6%

No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10kMar 2

Conviction: unchanged

GEHC FY2025 10-K: Healthcare Recovery with Tariff Headwinds

GEHC FY2025: Solid healthcare recovery thesis undermined by 2025 tariff materiality. Company explicitly warned tariffs materially hurt profitability; mitigation insufficient. Imaging capex cycle impro...